|
gptkbp:instanceOf
|
company
|
|
gptkbp:acquisition
|
gptkb:Becton,_Dickinson_and_Company
2017
|
|
gptkbp:CEO
|
gptkb:Timothy_M._Ring
|
|
gptkbp:employees
|
approximately 15,000
|
|
gptkbp:founded
|
1907
|
|
gptkbp:founder
|
gptkb:Charles_Russell_Bard
|
|
gptkbp:headquarters
|
gptkb:Murray_Hill,_New_Jersey
gptkb:Murray_Hill,_New_Jersey,_USA
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
C. R. Bard, Inc.
|
|
gptkbp:industry
|
medical devices
|
|
gptkbp:keyPeople
|
gptkb:Robert_J._McMahon
gptkb:David_A._Hager
gptkb:Michael_J._O'Neill
gptkb:Timothy_M._Ring
gptkb:James_C._O'Neill
John A. McGowan
|
|
gptkbp:market
|
$24 billion (2017)
|
|
gptkbp:parentCompany
|
gptkb:Becton,_Dickinson_and_Company
|
|
gptkbp:products
|
catheters
wound care products
surgical sutures
urology products
vascular access devices
|
|
gptkbp:revenue
|
$3.3 billion (2016)
|
|
gptkbp:stockSymbol
|
BCR
|
|
gptkbp:subsidiary
|
gptkb:Bard_Access_Systems
gptkb:Bard_Peripheral_Vascular
gptkb:Bard_Biopsy_Systems
Bard_Medical_Division
Bard_Electrophysiology
|
|
gptkbp:tradedOn
|
gptkb:NYSE
|
|
gptkbp:type
|
public company
|
|
gptkbp:website
|
www.crbard.com
|